Edition:
India

People: Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

18.70USD
1:30am IST
Change (% chg)

$0.20 (+1.08%)
Prev Close
$18.50
Open
$18.50
Day's High
$18.82
Day's Low
$18.50
Volume
1,892,917
Avg. Vol
355,327
52-wk High
$18.87
52-wk Low
$8.39

Streck, Paul 

Dr. Paul Streck M.D. is Chief Medical Officer of the Company. Dr. Streck has served as our Chief Medical Officer since January 2019. From June 2017 to January 2018, Dr. Streck served as Chief Medical Officer of Insmed Incorporated. From November 2015 to June 2017, Dr. Streck served as Vice President, Global Medical Specialty Franchise, Immuno-inflammation at GlaxoSmithKline plc. From November 2007 to November 2015, Dr. Streck held various positions at Shire Pharmaceuticals plc. Dr. Streck served as Group Vice President, Clinical Development/TA Lead (Hematology, Gastrointestinal, Internal Medicine) at Shire Pharmaceuticals from November 2013 to November 2015. Prior to that, Dr. Streck served as Global Head of Medical Affairs, Internal Medicine (November 2012 to December 2013), Product General Manager, Emerging Business Unit (November 2011 to November 2012), and Senior Director, Global Clinical Development (November 2007 to December 2012) at Shire Pharmaceuticals. From February 2006 to October 2007, Dr. Streck was Director of Marketing at AMGEN USA Inc. Dr. Streck holds an M.B.A. from the Duke University Fuqua School of Business, an M.D. from Jefferson Medical College, a D.M.D. from the Temple University School of Dentistry and a B.A. in chemistry from Rutgers University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Azelby

10,130,800

Carlos Campoy

1,844,370

Erin Lavelle

3,680,390

James Bucher

1,961,540

Randal Hassler

4,217,190

Nadia Dac

--
As Of  31 Dec 2018